Ingredient · Copper Tripeptide-1

GHK-Cu

GHK-Cu is a copper-binding tripeptide studied for its relationship with processes involved in skin remodeling. Skincare research has explored its potential to improve the appearance of fine lines, wrinkles, and aging skin.

GlyHisLysCu
Conceptual illustration, not a structural model.
Identity

Three amino acids and a copper ion

Its scientific name is glycyl-L-histidyl-L-lysine complexed with copper. In cosmetics, the ingredient name is commonly Copper Tripeptide-1.

Type
Copper-binding tripeptide
Common ingredient name
Copper Tripeptide-1
Studied for
Smoother-looking skin and improvements in the appearance of wrinkles
The evidence

What the research studied

Three areas matter most: laboratory work on collagen and elastin, limited human studies on wrinkles and texture, and the role of formulation and delivery.

Laboratory research

Collagen and elastin in cultured cells

In a 2016 study, human adult dermal fibroblasts were incubated with GHK-Cu at three concentrations. Collagen and elastin production increased at each concentration tested.1

What it cannot tell us: how skin responds when a product is applied. Cells in a dish are not a face.

Human formulation study

An eight-week randomized trial

The same paper reports a randomized, double-blind trial in 40 women aged 40 to 65. A GHK-Cu formulation in a lipid-based nano-carrier was applied to the face twice daily. The authors reported reductions in wrinkle volume compared with a control serum and with a comparison peptide product.1

What it cannot tell us: whether a different formula performs the same way. This was one small study of one specific delivery system.

Human studies, summarized in review

Earlier work on facial skin

A 2018 review describes earlier studies of GHK-Cu creams that reported improvements in the appearance of fine lines and skin texture after twelve weeks.2

What it cannot tell us: details we have not verified in the original reports. We cite the review as a summary, not as primary evidence.

Formulation and delivery

The carrier is part of the result

The human trial delivered GHK-Cu in a lipid-based carrier designed to help it reach the skin. That choice is inseparable from the outcome, which is why we treat delivery as a core formulation question.

No Clara Veyl finished-product studies exist yet. The findings above describe the ingredients and formulations tested by those researchers. They cannot automatically be applied to Clara Veyl products.

In plain terms

What we say, and what we do not

We describe GHK-Cu as an ingredient studied for the appearance of wrinkles and smoother-looking skin.

We do not claim that a Clara Veyl cosmetic rebuilds collagen, heals wounds, repairs DNA, reverses biological age, regenerates tissue or treats any condition. Laboratory findings are not product results.

References

  1. Badenhorst T, Svirskis D, Merrilees M, Bolke L, Wu Z. Effects of GHK-Cu on MMP and TIMP expression, collagen and elastin production, and facial wrinkle parameters. Journal of Aging Science. 2016;4:166. doi:10.4172/2329-8847.1000166
  2. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. 2018;19(7):1987. Full text